Think Research Engages Oak Hill as Advisor and Investor Relations Promoter
TORONTO, June 22, 2022 /CNW/ – Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) (“Think“or the”Company“), a health technology company focused on transforming healthcare through knowledge-based digital health software solutions, today announced that it has amended its existing consulting services agreement (the “Amended service contract“) with Oak Hill Financial Inc. (“Hill Oak“), following conditional approval from the TSX Venture Exchange (“TSXV“).
Under the Amended Services Agreement, Oak Hill will, in addition to existing services, provide investor relations activities and perform a promotional role for and on behalf of Think, as such terms are defined in the policies of the TSXV . All such services will comply with the policies and guidelines of the TSXV.
The Amended Services Agreement has an effective date of June 3, 2022 and the initial term will end March, 31st, 2023. Thereafter, the amended Service Agreement will automatically renew for successive twelve-month periods unless either party provides 60 days written notice of termination to the other party prior to the end of the term then In progress. In return for these services, Think will pay Hill Oak a monthly cash fee of $13,000 plus applicable taxes and reasonable expenses.
As announced on May 6, 2022the Company issued 74,380 ordinary shares in the capital of the Company for Hill Oak (there “Ordinary actions“), in return for services rendered to the Company up to March 31, 2022. With the exception of ordinary shares, neither Hill Oak nor any of its directors, officers or employees has any interest, direct or indirect, in Think or its securities, nor any right or intention to acquire such interest.
About Think Research Corporation
Think is an industry leader in providing knowledge-based digital healthcare software solutions. The company’s mission is to organize the world’s health knowledge so that everyone receives the best care. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care and improve patient outcomes. For more than a decade, Think’s cloud-based, EMR-independent digital tools have enabled clinicians around the world to positively impact millions of patients across the continuum of care, including primary medical care, acute care hospitals and operating theatres, as well as the community and the elderly. ‘ care. Think is proud to be a trusted healthcare system partner for a rapidly growing global customer base that spans five continents, in more than 13,000 healthcare facilities, with a clinical audience of over 300,000 physicians, nurses and pharmacists. Visit: www.thinkresearch.com
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For more information: https://www.thinkresearch.com/ca/investors/
SOURCEThink Research Corporation
Show original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/22/c5271.html